Style | Citing Format |
---|---|
MLA | Heshmatghahdarijani K, et al.. "The Neutrophil-To-Lymphocyte Ratio As a New Prognostic Factor in Cancers: A Narrative Review." Frontiers in Oncology, vol. 13, no. , 2023, pp. -. |
APA | Heshmatghahdarijani K, Sarmadi V, Heidari A, Falahati Marvasti A, Neshat S, Raeisi S (2023). The Neutrophil-To-Lymphocyte Ratio As a New Prognostic Factor in Cancers: A Narrative Review. Frontiers in Oncology, 13(), -. |
Chicago | Heshmatghahdarijani K, Sarmadi V, Heidari A, Falahati Marvasti A, Neshat S, Raeisi S. "The Neutrophil-To-Lymphocyte Ratio As a New Prognostic Factor in Cancers: A Narrative Review." Frontiers in Oncology 13, no. (2023): -. |
Harvard | Heshmatghahdarijani K et al. (2023) 'The Neutrophil-To-Lymphocyte Ratio As a New Prognostic Factor in Cancers: A Narrative Review', Frontiers in Oncology, 13(), pp. -. |
Vancouver | Heshmatghahdarijani K, Sarmadi V, Heidari A, Falahati Marvasti A, Neshat S, Raeisi S. The Neutrophil-To-Lymphocyte Ratio As a New Prognostic Factor in Cancers: A Narrative Review. Frontiers in Oncology. 2023;13():-. |
BibTex | @article{ author = {Heshmatghahdarijani K and Sarmadi V and Heidari A and Falahati Marvasti A and Neshat S and Raeisi S}, title = {The Neutrophil-To-Lymphocyte Ratio As a New Prognostic Factor in Cancers: A Narrative Review}, journal = {Frontiers in Oncology}, volume = {13}, number = {}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Heshmatghahdarijani K AU - Sarmadi V AU - Heidari A AU - Falahati Marvasti A AU - Neshat S AU - Raeisi S TI - The Neutrophil-To-Lymphocyte Ratio As a New Prognostic Factor in Cancers: A Narrative Review JO - Frontiers in Oncology VL - 13 IS - SP - EP - PY - 2023 ER - |